Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR7 | Q9NYK1 | 20/20 | 0.68 |
| ▸ | TLR8 | Q9NR97 | 12/20 | 0.68 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24808210 | 1.00 | TLR7 (0.68) | TLR7TLR8NUDT1 | |
| SCHEMBL23637762 | 0.90 | TLR7 (0.79) | TLR7TLR8NUDT1 | |
| SCHEMBL3518277 | 0.87 | TLR7 (0.75) | TLR7TLR8NUDT1 | |
| SCHEMBL29639770 | 0.87 | TLR7 (0.75) | TLR7TLR8NUDT1 | |
| SCHEMBL24808853 | 0.87 | TLR7 (0.75) | TLR7TLR8NUDT1 | |
| SCHEMBL24808069 | 0.85 | TLR7 (0.79) | TLR7TLR8NUDT1 | |
| SCHEMBL29639792 | 0.84 | TLR7 (0.71) | TLR7TLR8NUDT1 | |
| SCHEMBL24808484 | 0.84 | TLR7 (0.71) | TLR7TLR8NUDT1 | |
| SCHEMBL24807103 | 0.84 | TLR7 (0.76) | TLR7TLR8NUDT1 | |
| SCHEMBL29639786 | 0.84 | TLR7 (0.76) | TLR7TLR8NUDT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114599360-A | 4-amino-imidazoquinoline compounds and uses thereof | 骏达贸易有限公司 | 2022-06-07 | — | — | CN | claimed |
| US-20220411421-A1 | 4-AMINO-IMIDAZOQUINOLINE COMPOUNDS AND USE THEREOF | CHOU, YU-CHENG (TW) | 2022-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220411421-A1 | 4-AMINO-IMIDAZOQUINOLINE COMPOUNDS AND USE THEREOF | TLR7, TLR8, TLR6 | TLR7 1/4885TLR8 2/4885NUDT1 789/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.